Top Ten Issues in Health Law Podcast Series

Hilary Isacson, Assistant General Counsel, Sutter Health, speaks with Daniel J. Hettich, Partner, King & Spalding LLP, about the impact that the Supreme Court’s Loper Bright decision is having on Medicare reimbursement. They discuss the impact on CMS’ approach to rulemaking and whether providers will have more opportunities to challenge CMS actions, how providers should navigate this new environment, and important cases to follow. From AHLA’s Regulation, Accreditation, and Payment Practice Group.

+Listen to Episode 1

Jennifer Kreick, Partner, Haynes Boone, speaks with Jeremy Sherer, Partner, Orrick Herrington & Sutcliffe LLP, about the various telehealth legal issues coming down the pike in 2025. They discuss the future of Medicare telehealth flexibilities, government scrutiny of telehealth and current enforcement initiatives, and requirements around controlled substance prescribing and in-person visits. From AHLA's Health Information and Technology Practice Group.

+Listen to Episode 2

Joe Wolfe, Attorney, Hall Render Killian Heath & Lyman PC, speaks with Ilene Albala, Partner, Goodwin Procter LLP, about how the new administration could reshape the health care fraud and abuse landscape. They discuss potential impacts on fraud and abuse enforcement and the False Claims Act in particular, possible challenges to the constitutionality of the False Claims Act, and the Anti-Kickback and Stark regulatory outlook. From AHLA's Fraud and Abuse Practice Group.

+Listen to Episode 3

H. Kristie Xian, Associate, Jones Day, speaks with Katherine I. Funk, Shareholder, Baker Donelson Bearman Caldwell & Berkowitz PC, about how the new administration might approach health care antitrust enforcement. They discuss the new Merger Guidelines, the revised Hart-Scott-Rodino filing rules, the interim report on pharmacy benefit managers, and where enforcement may diverge from the prior administration. From AHLA’s Antitrust Practice Group.

+Listen to Episode 4

Mary R. Kohler, Founder & Principal, Kohler Health Law PC, speaks with Sheela Ranganathan, Adjunct Professor, Georgetown University School of Health, about the current legal and regulatory landscape surrounding medication abortion. They discuss the history of challenges to mifepristone and misoprostol; how recent cases are playing out, including Alliance for Hippocratic Medicine v. FDA, GenBioPro v. Raynes et al., and Bryant v. Stein; and what to expect from the new administration. From AHLA’s Life Sciences Practice Group.

+Listen to Episode 5

Elizabeth Trende, Chief Legal Officer & General Counsel, United Network for Organ Sharing, speaks with Michelle Garvey Brennfleck, Shareholder, Buchanan Ingersoll & Rooney, about the current cyber threat environment for the health care industry and what health care entities can do to better protect themselves from cyberattacks. They discuss the proposed Health Infrastructure Security and Accountability Act, the importance of cyber risk assessments, and how the new administration may impact policies on protected health information. From AHLA’s Academic Medical Centers and Teaching Hospitals Practice Group.

+Listen to Episode 6

Christianna Finnern, Shareholder, Winthrop & Weinstine PA, speaks with Noreen Vergara, Partner, Husch Blackwell LLP, about the Mental Health Parity and Addiction Equity Act (MHPAEA) and its requirements. They discuss some of the changes in the final rule, whether the new administration or the Loper Bright Supreme Court case will affect compliance and enforcement of MHPAEA, and how MHPAEA impacts average health care consumers and those who don’t work in the benefits and managed care space. From AHLA’s Behavioral Health Practice Group.

+Listen to Episode 7

Shalyn Watkins, Associate, Holland & Knight LLP, speaks with Anjali B. Dooley, Senior Partner, DBM Legal Services LLC, about the key litigation risks that are coming to the forefront regarding the use of artificial intelligence. They discuss issues related to accountability, strict liability versus negligence, data lineage and bias, and validation/reliability. From AHLA’s Health Care Liability and Litigation Practice Group.

+Listen to Episode 8

Adam Laughton, Shareholder, Greenberg Traurig LLP, speaks with Jennifer Nelson Carney, Member, Epstein Becker & Green PC, about the latest developments related to gender affirming care. They discuss what gender affirming care is; state legislative and medical board activities; the Skrmetti case; Trump Administration executive actions, federal agency memos, and ensuing litigation; and how to counsel health care providers in this rapidly changing environment. From AHLA's Physician Organizations Practice Group.

+Listen to Episode 9

Ragini Acharya, Partner, Husch Blackwell LLP, speaks with William S. Richmond, Partner, Kirkland & Ellis LLP, about the latest developments related to state health care transaction review laws. They discuss the growth in the number of states introducing new or expanding current health care transaction review laws; trends related to notice versus consent; the types of transactions these laws apply to; and how parties to transactions should navigate the variation in state timing requirements, contingency planning, and confidentiality of deal terms. From AHLA’s Business Law and Governance Practice Group.

+Listen to Episode 10